169 related articles for article (PubMed ID: 25498098)
1. Risk factors for hepatotoxicity in solid organ transplants recipients being treated for tuberculosis.
Schultz V; Marroni CA; Amorim CS; Baethgen LF; Pasqualotto AC
Transplant Proc; 2014 Dec; 46(10):3606-10. PubMed ID: 25498098
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
[TBL] [Abstract][Full Text] [Related]
3. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review.
Abad CLR; Deziel PJ; Razonable RR
Transpl Infect Dis; 2019 Dec; 21(6):e13178. PubMed ID: 31541575
[TBL] [Abstract][Full Text] [Related]
4. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients.
Ha YE; Joo EJ; Park SY; Wi YM; Kang CI; Chung DR; Joh JW; Lee SK; Song JH; Peck KR
Transpl Infect Dis; 2012 Dec; 14(6):626-34. PubMed ID: 22372581
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis in recipients of solid-organ transplants during 1995-2015 in Cali, Colombia.
García-Goez JF; Munera GA; Rojas V; Pacheco R; Caylá JA; Miro JM
Int J Tuberc Lung Dis; 2017 Nov; 21(11):1155-1159. PubMed ID: 29037296
[TBL] [Abstract][Full Text] [Related]
7. Treating tuberculosis in solid organ transplant recipients.
Sun HY
Curr Opin Infect Dis; 2014 Dec; 27(6):501-5. PubMed ID: 25211360
[TBL] [Abstract][Full Text] [Related]
8. A nationwide population-based study of the risk of tuberculosis in different solid organ transplantations in Taiwan.
Chen CH; Shu KH; Ho HC; Cheng SB; Lin CC; Wei HJ; Lin CH; Chang SN; Wu MJ
Transplant Proc; 2014 May; 46(4):1032-5. PubMed ID: 24815120
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort.
Torre-Cisneros J; Doblas A; Aguado JM; San Juan R; Blanes M; Montejo M; Cervera C; Len O; Carratala J; Cisneros JM; Bou G; Muñoz P; Ramos A; Gurgui M; Borrell N; Fortún J; Moreno A; Gavalda J;
Clin Infect Dis; 2009 Jun; 48(12):1657-65. PubMed ID: 19445585
[TBL] [Abstract][Full Text] [Related]
10. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period.
Sidhu A; Verma G; Humar A; Kumar D
Transplantation; 2014 Sep; 98(6):671-5. PubMed ID: 24825525
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis in Egyptian kidney transplant recipients: study of clinical course and outcome.
el-Agroudy AE; Refaie AF; Moussa OM; Ghoneim MA
J Nephrol; 2003; 16(3):404-11. PubMed ID: 12832742
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.
Aguado JM; Herrero JA; Gavaldá J; Torre-Cisneros J; Blanes M; Rufí G; Moreno A; Gurguí M; Hayek M; Lumbreras C; Cantarell C
Transplantation; 1997 May; 63(9):1278-86. PubMed ID: 9158022
[TBL] [Abstract][Full Text] [Related]
13. Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high-endemic country.
Kwon DE; Han SH; Han KD; La Y; Lee KH
Transpl Infect Dis; 2021 Dec; 23(6):e13729. PubMed ID: 34505751
[TBL] [Abstract][Full Text] [Related]
14. Prevention and treatment of tuberculosis in solid organ transplant recipients.
Abad CL; Razonable RR
Expert Rev Anti Infect Ther; 2020 Jan; 18(1):63-73. PubMed ID: 31826668
[No Abstract] [Full Text] [Related]
15. Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis.
Al-Mukhaini SM; Al-Eid H; Alduraibi F; Hakami HI; Talhi HA; Shoukri M; Ahmed AM; Ahmed Y; Alrajhi AA
Ann Saudi Med; 2017; 37(2):138-143. PubMed ID: 28377543
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases.
Abad CLR; Razonable RR
Clin Transplant; 2018 Jun; 32(6):e13259. PubMed ID: 29656530
[TBL] [Abstract][Full Text] [Related]
17. Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates.
de Castilla DL; Rakita RM; Spitters CE; Narita M; Jain R; Limaye AP
Transplantation; 2014 Jan; 97(2):206-11. PubMed ID: 24142036
[TBL] [Abstract][Full Text] [Related]
18. Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.
Isa SE; Ebonyi AO; Shehu NY; Idoko P; Anejo-Okopi JA; Simji G; Odesanya RU; Abah IO; Jimoh HO
Int J Mycobacteriol; 2016 Mar; 5(1):21-6. PubMed ID: 26927986
[TBL] [Abstract][Full Text] [Related]
19. First line anti-tuberculosis induced hepatotoxicity: incidence and risk factors.
Bouazzi OE; Hammi S; Bourkadi JE; Tebaa A; Tanani DS; Soulaymani-Bencheikh R; Badrane N; Bengueddour R
Pan Afr Med J; 2016; 25():167. PubMed ID: 28292129
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil.
Heinrich MM; Zembrzuski VM; Ota MM; Sacchi FP; Teixeira RL; Cabello Acero PH; Cunha GM; Souza-Santos R; Croda J; Basta PC
Tuberculosis (Edinb); 2016 Dec; 101():15-24. PubMed ID: 27865386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
